Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine

Abstract Background Pituitary adenylate cyclase-activating polypeptide (PACAP) is widely distributed in the nervous system and is involved in migraine pathophysiology. Understanding the function of the blood-brain barrier (BBB) in relation to PACAP is important to the understand the mechanisms behin...

Full description

Bibliographic Details
Main Authors: Faisal Mohammad Amin, Henrik Winther Schytz
Format: Article
Language:English
Published: BMC 2018-05-01
Series:The Journal of Headache and Pain
Subjects:
Online Access:http://link.springer.com/article/10.1186/s10194-018-0861-3
_version_ 1818021684000587776
author Faisal Mohammad Amin
Henrik Winther Schytz
author_facet Faisal Mohammad Amin
Henrik Winther Schytz
author_sort Faisal Mohammad Amin
collection DOAJ
description Abstract Background Pituitary adenylate cyclase-activating polypeptide (PACAP) is widely distributed in the nervous system and is involved in migraine pathophysiology. Understanding the function of the blood-brain barrier (BBB) in relation to PACAP is important to the understand the mechanisms behind PACAP-induced migraine attacks, but also to develop antimigraine drugs targeting the PACAP receptors Here, we aim to review the transport ability of PACAP across the BBB. Methods We performed a systematic literature search on PubMed to identify studies reporting original data on PACAP and BBB. The search was finalized in July 2017. Results The literature search identified 96 papers of which 11 contained relevant data. In addition, two papers were known to be relevant and were included. A total of 13 papers studies were included in the final analysis. Preclinical studies (n = 10) suggest the existence of specific PACAP transport systems across the BBB, while human PACAP studies failed to show vasodilator effect of PACAP on the cerebral arteries from the lumen (n = 3). Conclusion PACAP38 is transported over the BBB actively, while PACAP27 cross the BBB by diffusion over the membrane, but after crossing the endothelial membrane both isoforms are either rapidly degraded or efflux back from brain to blood. Thus, a direct central action of the PACAPs is unlikely. This is supported by studies showing selective PACAP effect on extra-cerebral arteries.
first_indexed 2024-04-14T08:21:04Z
format Article
id doaj.art-8b0cb5e710694bf082a5f2bd72b45204
institution Directory Open Access Journal
issn 1129-2369
1129-2377
language English
last_indexed 2024-04-14T08:21:04Z
publishDate 2018-05-01
publisher BMC
record_format Article
series The Journal of Headache and Pain
spelling doaj.art-8b0cb5e710694bf082a5f2bd72b452042022-12-22T02:04:12ZengBMCThe Journal of Headache and Pain1129-23691129-23772018-05-011911610.1186/s10194-018-0861-3Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraineFaisal Mohammad Amin0Henrik Winther Schytz1Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of CopenhagenDanish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of CopenhagenAbstract Background Pituitary adenylate cyclase-activating polypeptide (PACAP) is widely distributed in the nervous system and is involved in migraine pathophysiology. Understanding the function of the blood-brain barrier (BBB) in relation to PACAP is important to the understand the mechanisms behind PACAP-induced migraine attacks, but also to develop antimigraine drugs targeting the PACAP receptors Here, we aim to review the transport ability of PACAP across the BBB. Methods We performed a systematic literature search on PubMed to identify studies reporting original data on PACAP and BBB. The search was finalized in July 2017. Results The literature search identified 96 papers of which 11 contained relevant data. In addition, two papers were known to be relevant and were included. A total of 13 papers studies were included in the final analysis. Preclinical studies (n = 10) suggest the existence of specific PACAP transport systems across the BBB, while human PACAP studies failed to show vasodilator effect of PACAP on the cerebral arteries from the lumen (n = 3). Conclusion PACAP38 is transported over the BBB actively, while PACAP27 cross the BBB by diffusion over the membrane, but after crossing the endothelial membrane both isoforms are either rapidly degraded or efflux back from brain to blood. Thus, a direct central action of the PACAPs is unlikely. This is supported by studies showing selective PACAP effect on extra-cerebral arteries.http://link.springer.com/article/10.1186/s10194-018-0861-3MigrainePACAPBlood-brain barrier
spellingShingle Faisal Mohammad Amin
Henrik Winther Schytz
Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
The Journal of Headache and Pain
Migraine
PACAP
Blood-brain barrier
title Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
title_full Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
title_fullStr Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
title_full_unstemmed Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
title_short Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
title_sort transport of the pituitary adenylate cyclase activating polypeptide across the blood brain barrier implications for migraine
topic Migraine
PACAP
Blood-brain barrier
url http://link.springer.com/article/10.1186/s10194-018-0861-3
work_keys_str_mv AT faisalmohammadamin transportofthepituitaryadenylatecyclaseactivatingpolypeptideacrossthebloodbrainbarrierimplicationsformigraine
AT henrikwintherschytz transportofthepituitaryadenylatecyclaseactivatingpolypeptideacrossthebloodbrainbarrierimplicationsformigraine